Evidence map›Paper›PMID 34950138›Full record

ArticleFrontiers in immunology2021

Multiple Tolerization Subtractive Immunization (MTSI) Protocol: Effects on Mice and Monoclonal Antibody Specificity.

Marina de Lima Fontes, Franciny Mara de Lima Neves, Kelvin Sousa Santos, Ana Marisa Fusco-Almeida, Maria José Soares Mendes Giannini, Sergio Luis Felisbino, Elenice Deffune, Andrei Moroz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marina de Lima FontesDepartment of Clinical Analysis, Monoclonal Antibody Laboratory, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Franciny Mara de Lima NevesDepartment of Clinical Analysis, Monoclonal Antibody Laboratory, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Kelvin Sousa SantosDepartment of Clinical Analysis, Monoclonal Antibody Laboratory, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Ana Marisa Fusco-AlmeidaDepartment of Clinical Analysis, Monoclonal Antibody Laboratory, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Maria José Soares Mendes GianniniDepartment of Clinical Analysis, Monoclonal Antibody Laboratory, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Sergio Luis FelisbinoDepartment of Morphology, Extracellular Matrix Laboratory, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, Brazil.
Elenice DeffuneDepartment of Urology, Tissue Engineering Laboratory, School of Medicine, São Paulo State University (UNESP), Botucatu, Brazil.
Andrei MorozDepartment of Clinical Analysis, Monoclonal Antibody Laboratory, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Universidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monoclonal antibodies (mAbs) have been a valuable tool to elucidate several biological processes, such as stem cell differentiation and cancer, and contributed to virtually all areas of biomedical sciences. Yet, it remains a challenge to obtain mAbs specific to poorly expressed epitopes, or to epitopes that are actually involved in important biological phenomena, such as cell differentiation and metastasis. Drug-induced subtractive immunization, and recently the multiple tolerization subtractive immunization (MTSI) technique, reported by our group, have the potential to level up the field, as they direct the host´s immune response towards these epitopes. However, due to cyclophosphamide (CY) treatment, high mice mortality can be observed, and only a few data are available on how these techniques affect the immune system of mice. Tolerogen and immunogen cells, RWPE-1 and PC-3 cells, respectively, were individually seeded at 2 × 10

Indexed as

AnimalsAntibodies, MonoclonalAntibody SpecificityCell LineCyclophosphamideEpitopesHumansImmunosuppression TherapyImmunosuppressive AgentsLeukocyte CountMaleMiceMice, Inbred BALB CAntibodies, MonoclonalCyclophosphamideEpitopesImmunosuppressive Agentscyclophosphamidemonoclonal antibodymultiple tolerization subtractive immunizationsurface-epitope maskingtumor biomarkers.

Identifiers

PMID34950138
PMCPMC8688850
OpenAlexW4200175785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.